IL22 and bacterial infectious disease: Given the similarity between COVID-19 and the Flu for the risk of the exacerbation of secondary bacterial infection, a beneficial effect of IL-22 in limiting disease severity has also recently been proposed for SARS-CoV-2 infection [118].